Danaher Announces Board Restructuring and New Appointments
1 report, 1 independent
Updated Oct 12
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Danaher Corporation announced the appointment of Daniel L. Comas and Robert Hershberg, M.D., Ph.D., to its board of directors on October 9, 2026. The company expanded its board size from 11 to 13 directors. Alan G. Spoon will retire from the board at the 2027 Annual Meeting of Shareholders. Steven M. Rales continues as Chairman of the Danaher Board of Directors.
From prnewswire.com
Why it matters
The restructuring reflects Danaher's commitment to maintaining a board with diverse expertise to support long-term growth and value creation. Robert Hershberg brings scientific, clinical, and biopharmaceutical expertise to the board.
From prnewswire.com
Who's involved
- DHRDanaher Corporation, the company undergoing the board changes.
- board of directorsThe governing body of Danaher Corporation that made the appointments.
- RalesSteven M. Rales, Chairman of the Danaher Board of Directors.
- SpoonAlan G. Spoon, director who will retire from the board.
- RobRobert Hershberg, M.D., Ph.D., newly appointed director bringing scientific expertise.
Keep exploring
The entities involved
-
DHR
advocacy organization
-
board of directors
group of people who jointly supervise the activities of an organization